Back
Cintas Corp. 10K Form
Sell
27
CTAS
Cintas Corp.
Last Price:
$174.28
Seasonality Move:
5.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-05 | 10Q | CTAS/Cintas Corp. Quarterly |
| 2024-01-08 | 10Q | CTAS/Cintas Corp. Quarterly |
| 2023-10-05 | 10Q | CTAS/Cintas Corp. Quarterly |
| 2023-07-27 | 10K | CTAS/Cintas Corp. Annual |
| 2023-04-06 | 10Q | CTAS/Cintas Corp. Quarterly |
| 2023-01-06 | 10Q | CTAS/Cintas Corp. Quarterly |
Receive CTAS News And Ratings
See the #1 stock for the next 7 days that we like better than CTAS
CTAS Financial Statistics
Sales & Book Value
| Annual Sales: | $10.3B |
|---|---|
| Cash Flow: | $530.6M |
| Price / Cash Flow: | 40.23 |
| Annual Sales: | $11.97 |
| Price / Book: | 14.75 |
Profitability
| EPS (TTM): | 4.74260 |
|---|---|
| Net Income (TTM): | $1.9B |
| Gross Margin: | $5B |
| Return on Equity: | 41.51% |
| Return on Assets: | 19.33% |
Cintas Corp. Earnings Forecast
Key Cintas Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for CTAS is 48.19%.
-
The Selling, General & Administrative Expenses for CTAS have been equal to 27.22% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 6.05% of Operating Income.
-
The Net Earning history of CTAS is 17.47% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 36 years.
Cintas Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | CTAS |
| CUSIP: | 172908 |
| Website: | cintas.com |
Debt
| Debt-to-Equity Ratio: | 0.61 |
|---|---|
| Current Ratio: | 1.98 |
| Quick Ratio: | 0.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 40.12 |
|---|---|
| Forward P/E Ratio: | 32.56 |
CTAS Technical Analysis vs Fundamental Analysis
Sell
27
Cintas Corp. (CTAS)
is a Sell
Is Cintas Corp. a Buy or a Sell?
-
Cintas Corp. stock is rated a SellThe current Cintas Corp. [CTAS] share price is $174.34. The Score for CTAS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.